semaglutide getting banned A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company FDA crackdown on off-brand Ozempic

Q: Why does this feel sudden

These genetic insights map across 14 metabolic pathways and 150+ clinical markers, allowing your provider to estimate how well your body will respond to semaglutide and design a treatment duration tailored to your genetics and physiology

Conclusion: Underwriters require additional information regarding Compounded Medical Weight Loss Medications in light of growing litigation

Treatment must be provided by specialist weight management services, is limited to a maximum of 2 years, and requires specific weight loss targets to continue

Shaat 1 , N.F

MASH: metabolic dysfunction-associated steatohepatitis